Taro Pharmaceutical Industries Ltd. Debt to Equity Ratio 2010-2023 | TARO
Current and historical debt to equity ratio values for Taro Pharmaceutical Industries Ltd. (TARO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Taro Pharmaceutical Industries Ltd. debt/equity for the three months ending December 31, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-12-31 | $0.38B | $1.78B | 0.22 |
| 2023-09-30 | $0.37B | $1.75B | 0.21 |
| 2023-06-30 | $0.40B | $1.74B | 0.23 |
| 2023-03-31 | $0.41B | $1.73B | 0.23 |
| 2022-12-31 | $0.40B | $1.72B | 0.23 |
| 2022-09-30 | $0.40B | $1.71B | 0.24 |
| 2022-06-30 | $0.41B | $1.71B | 0.24 |
| 2022-03-31 | $0.47B | $1.71B | 0.27 |
| 2021-12-31 | $0.43B | $1.70B | 0.25 |
| 2021-09-30 | $0.64B | $1.67B | 0.39 |
| 2021-06-30 | $0.76B | $1.66B | 0.46 |
| 2021-03-31 | $0.71B | $1.70B | 0.42 |
| 2020-12-31 | $0.62B | $1.75B | 0.36 |
| 2020-09-30 | $0.63B | $1.72B | 0.37 |
| 2020-06-30 | $0.71B | $1.67B | 0.42 |
| 2020-03-31 | $0.23B | $2.11B | 0.11 |
| 2019-12-31 | $0.22B | $2.07B | 0.11 |
| 2019-09-30 | $0.22B | $2.03B | 0.11 |
| 2019-06-30 | $0.20B | $1.98B | 0.10 |
| 2019-03-31 | $0.22B | $1.91B | 0.12 |
| 2018-12-31 | $0.22B | $1.85B | 0.12 |
| 2018-09-30 | $0.21B | $2.35B | 0.09 |
| 2018-06-30 | $0.20B | $2.28B | 0.09 |
| 2018-03-31 | $0.22B | $2.21B | 0.10 |
| 2017-12-31 | $0.22B | $2.20B | 0.10 |
| 2017-09-30 | $0.21B | $2.21B | 0.09 |
| 2017-06-30 | $0.21B | $2.15B | 0.10 |
| 2017-03-31 | $0.22B | $2.07B | 0.10 |
| 2016-12-31 | $0.25B | $2.00B | 0.12 |
| 2016-09-30 | $0.23B | $1.92B | 0.12 |
| 2016-06-30 | $0.25B | $1.92B | 0.13 |
| 2016-03-31 | $0.25B | $1.94B | 0.13 |
| 2015-12-31 | $0.25B | $1.94B | 0.13 |
| 2015-09-30 | $0.29B | $1.62B | 0.18 |
| 2015-06-30 | $0.26B | $1.53B | 0.17 |
| 2015-03-31 | $0.32B | $1.42B | 0.23 |
| 2014-12-31 | $0.28B | $1.32B | 0.21 |
| 2014-09-30 | $0.25B | $1.20B | 0.20 |
| 2014-06-30 | $0.26B | $1.09B | 0.24 |
| 2014-03-31 | $0.26B | $1.02B | 0.26 |
| 2013-12-31 | $0.26B | $0.95B | 0.27 |
| 2013-09-30 | $0.25B | $1.04B | 0.24 |
| 2013-06-30 | $0.24B | $0.94B | 0.26 |
| 2013-03-31 | $0.22B | $0.89B | 0.24 |
| 2012-12-31 | $0.20B | $0.85B | 0.23 |
| 2012-09-30 | $0.21B | $0.76B | 0.27 |
| 2012-06-30 | $0.19B | $0.69B | 0.28 |
| 2012-03-31 | $0.23B | $0.62B | 0.38 |
| 2011-12-31 | $0.23B | $0.57B | 0.39 |
| 2011-09-30 | $0.21B | $0.50B | 0.42 |
| 2011-06-30 | $0.18B | $0.46B | 0.39 |
| 2011-03-31 | $0.18B | $0.42B | 0.42 |
| 2010-12-31 | $0.18B | $0.38B | 0.46 |
| 2010-09-30 | $0.25B | $0.30B | 0.83 |
| 2010-06-30 | $0.26B | $0.26B | 1.03 |
| 2010-03-31 | $0.28B | $0.25B | 1.13 |
| 2009-12-31 | $0.27B | $0.24B | 1.14 |
| 2009-09-30 | $0.30B | $0.23B | 1.30 |
| 2009-06-30 | $0.27B | $0.21B | 1.26 |
| 2009-03-31 | $0.27B | $0.20B | 1.35 |
